4890 Stock Overview
Engages in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Tsubota Laboratory Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥388.00 |
| 52 Week High | JP¥625.00 |
| 52 Week Low | JP¥252.00 |
| Beta | 1.78 |
| 1 Month Change | -11.42% |
| 3 Month Change | -13.39% |
| 1 Year Change | 15.82% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -54.30% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4890 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -1.5% | 2.8% | 3.6% |
| 1Y | 15.8% | 12.8% | 16.3% |
Return vs Industry: 4890 exceeded the JP Pharmaceuticals industry which returned 12.8% over the past year.
Return vs Market: 4890 matched the JP Market which returned 16.3% over the past year.
Price Volatility
| 4890 volatility | |
|---|---|
| 4890 Average Weekly Movement | 4.5% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.2% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4890 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4890's weekly volatility has decreased from 11% to 4% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 7 | Kazuo Tsubota | www.tsubota-lab.com |
Tsubota Laboratory Incorporated engages in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia. The company was incorporated in 2012 and is based in Tokyo, Japan.
Tsubota Laboratory Incorporated Fundamentals Summary
| 4890 fundamental statistics | |
|---|---|
| Market cap | JP¥9.92b |
| Earnings (TTM) | -JP¥304.00m |
| Revenue (TTM) | JP¥1.11b |
8.9x
P/S Ratio-32.6x
P/E RatioIs 4890 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4890 income statement (TTM) | |
|---|---|
| Revenue | JP¥1.11b |
| Cost of Revenue | JP¥528.00m |
| Gross Profit | JP¥582.00m |
| Other Expenses | JP¥886.00m |
| Earnings | -JP¥304.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 12, 2025
| Earnings per share (EPS) | -11.89 |
| Gross Margin | 52.43% |
| Net Profit Margin | -27.39% |
| Debt/Equity Ratio | 7.2% |
How did 4890 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 19:44 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Tsubota Laboratory Incorporated is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|